Edition:
United Kingdom

OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

105JPY
25 Jun 2019
Change (% chg)

-- (--)
Prev Close
¥105
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
988,353
52-wk High
¥185
52-wk Low
¥105

Latest Key Developments (Source: Significant Developments)

OncoTherapy Science unit says joint development with Japanese Foundation For Cancer Research
Thursday, 1 Mar 2018 

March 1 (Reuters) - OncoTherapy Science Inc <4564.T>:Says co's unit Cancer Precision Medicine signs joint development agreement with Japanese Foundation For Cancer Research.Says two entities will cooperate on development of genetic variation in cancer .  Full Article

OncoTherapy Science unit says business alliance with Thermo Fisher Scientific
Thursday, 15 Feb 2018 

Feb 15 (Reuters) - OncoTherapy Science Inc <4564.T>:Says its unit, Cancer Precision Medicine forms business alliance with Thermo Fisher Scientific .Says two entities mainly cooperate on evaluation of liquid biopsy platform based on Ion Torrent Oncomine Pan-Cancer Cell-Free Assay .  Full Article

OncoTherapy Science says close of peptide vaccine related agreement with ONO PHARMACEUTICAL
Wednesday, 2 Aug 2017 

Aug 2 (Reuters) - OncoTherapy Science Inc <4564.T>:* Says peptide vaccine related agreement with.  Full Article

OncoTherapy Science says business and capital alliance with Theragen Etex
Wednesday, 12 Jul 2017 

July 12 (Reuters) - OncoTherapy Science Inc <4564.T>:* Says it will establish a wholly owened subsidary on July 24.* Say it will transfer research and development of cancer immunotherapy related business to the subsidiary, effective Nov. 1 .* The subsidary will issue 150 new shares to Theragen Etex Co., Ltd. <066700.KQ>, at the price of 1 million yen per share, or 150 million yen in total, and payment date on Aug. 7 .* Theragen Etex Co., Ltd. will acquire 310 shares of the subsidiary, at the price of 1 million yen, for 310 million yen in total, from the co, effective Nov. 15 .* Say the co and Theragen Etex Co., Ltd. Will hold a 64 percent stake and a 36 percent stake finally .  Full Article